1722-25-4

Applied Filters:

Keyword:'1722-25-4'

Showing 1-2 of 2 results for "1722-25-4" within Papers

[Association of CTLA-4 promoter -1722 polymorphism with systemic lupus erythematosus in Chinese].

An-ping Xu et al.

Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA, 24(10), 1107-1112 (2004-10-16)

To investigate the possible association of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) promoter -1722 polymorphism with systemic lupus erythematosus (SLE) in the population in southern China. A total of 103 SLE patients (13 males and 90 females with an average

In-vitro immunosuppression of canine T-lymphocyte-specific proliferation with dexamethasone, cyclosporine, and the active metabolites of azathioprine and leflunomide in a flow-cytometric assay.

Laura A Nafe et al.

Canadian journal of veterinary research = Revue canadienne de recherche veterinaire, 78(3), 168-175 (2014-07-02)

A high rate of mortality, expense, and complications of immunosuppressive therapy in dogs underscores the need for optimization of drug dosing. The purpose of this study was to determine, using a flow-cytometric assay, the 50% T-cell inhibitory concentration (IC50) of

Page 1 of 1